$ADVM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adverum Biotechnologies, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Adverum Biotechnologies, Inc.. Get notifications about new insider transactions in Adverum Biotechnologies, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14 2021 | ADVM | Adverum Biotechnol ... | Woiwode Thomas | Director | Option Exercise | A | 3.70 | 40,000 | 148,000 | 40,000 | |
| May 14 2021 | ADVM | Adverum Biotechnol ... | Whitcup Scott M | Director | Option Exercise | A | 3.70 | 40,000 | 148,000 | 40,000 | |
| May 14 2021 | ADVM | Adverum Biotechnol ... | Svoronos Dawn | Director | Option Exercise | A | 3.70 | 40,000 | 148,000 | 40,000 | |
| May 14 2021 | ADVM | Adverum Biotechnol ... | Scopa James Paul | Director | Option Exercise | A | 3.70 | 40,000 | 148,000 | 40,000 | |
| May 14 2021 | ADVM | Adverum Biotechnol ... | Lupher, Jr. Mark L. | Director | Option Exercise | A | 3.70 | 40,000 | 148,000 | 40,000 | |
| May 14 2021 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | A | 3.70 | 40,000 | 148,000 | 40,000 | |
| May 14 2021 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Option Exercise | A | 3.70 | 12,500 | 46,250 | 12,500 | |
| May 14 2021 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Option Exercise | A | 3.70 | 40,000 | 148,000 | 40,000 | |
| Apr 01 2021 | ADVM | Adverum Biotechnol ... | Svoronos Dawn | Director | Buy | P | 10.02 | 20,000 | 200,338 | 20,000 | 0 to 20 K |
| Mar 24 2021 | ADVM | Adverum Biotechnol ... | Fischer Laurent | CEO and Director | Buy | P | 9.88 | 10,000 | 98,780 | 26,292 | 16.3 K to 26.3 K (+61.38 %) |
| Mar 24 2021 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Buy | P | 9.92 | 10,000 | 99,196 | 88,182 | 78.2 K to 88.2 K (+12.79 %) |
| Feb 23 2021 | ADVM | Adverum Biotechnol ... | Tuckson Reed Vaughn | Director | Option Exercise | A | 12.85 | 45,000 | 578,250 | 45,000 | |
| Feb 18 2021 | ADVM | Adverum Biotechnol ... | Thedinga Angela | Chief Technology Of ... | Option Exercise | A | 13.44 | 250,000 | 3,360,000 | 250,000 | |
| Feb 18 2021 | ADVM | Adverum Biotechnol ... | Soparkar Peter | Chief Legal Officer | Option Exercise | A | 13.44 | 140,000 | 1,881,600 | 140,000 | |
| Feb 18 2021 | ADVM | Adverum Biotechnol ... | Osborne Aaron | Chief Medical Offic ... | Option Exercise | A | 13.44 | 150,000 | 2,016,000 | 150,000 | |
| Feb 18 2021 | ADVM | Adverum Biotechnol ... | PATTERSON LEONE D | President and CFO | Option Exercise | A | 13.44 | 240,000 | 3,225,600 | 240,000 | |
| Feb 18 2021 | ADVM | Adverum Biotechnol ... | Fischer Laurent | CEO and Director | Option Exercise | A | 13.44 | 680,000 | 9,139,200 | 680,000 | |
| Feb 11 2021 | ADVM | Adverum Biotechnol ... | PATTERSON LEONE D | President and CFO | Sell | S | 14.14 | 62 | 877 | 97,955 | 98 K to 98 K (-0.06 %) |
| Feb 11 2021 | ADVM | Adverum Biotechnol ... | PATTERSON LEONE D | President and CFO | Sell | S | 14.10 | 12,471 | 175,841 | 98,017 | 110.5 K to 98 K (-11.29 %) |
| Jan 19 2021 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Buy | P | 11.52 | 10,000 | 115,174 | 78,182 | 68.2 K to 78.2 K (+14.67 %) |
| Jan 19 2021 | ADVM | Adverum Biotechnol ... | Fischer Laurent | CEO and Director | Buy | P | 11.53 | 8,600 | 99,191 | 16,292 | 7.7 K to 16.3 K (+111.80 %) |
| Dec 16 2020 | ADVM | Adverum Biotechnol ... | Woiwode Thomas | Director | Buy | J | 0.00 | 12,783 | 0 | 18,822 | 6 K to 18.8 K (+211.67 %) |
| Dec 11 2020 | ADVM | Adverum Biotechnol ... | Svoronos Dawn | Director | Option Exercise | A | 12.82 | 45,000 | 576,900 | 45,000 | |
| Aug 19 2020 | ADVM | Adverum Biotechnol ... | Soparkar Peter | Chief Legal Officer | Buy | P | 13.00 | 7,692 | 99,996 | 10,692 | 3 K to 10.7 K (+256.40 %) |
| Aug 19 2020 | ADVM | Adverum Biotechnol ... | Fischer Laurent | CEO and Director | Buy | P | 13.00 | 7,692 | 99,996 | 7,692 | 0 to 7.7 K |
| Jul 22 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 5,000 | 24,000 | 78,000 | |
| Jul 22 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 17.60 | 5,000 | 87,978 | 274,442 | 279.4 K to 274.4 K (-1.79 %) |
| Jul 22 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 5,000 | 24,000 | 279,442 | 274.4 K to 279.4 K (+1.82 %) |
| Jul 22 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 5,000 | 24,000 | 78,000 | |
| Jul 22 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 17.60 | 5,000 | 87,978 | 274,442 | 279.4 K to 274.4 K (-1.79 %) |
| Jul 22 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 5,000 | 24,000 | 279,442 | 274.4 K to 279.4 K (+1.82 %) |
| Jun 25 2020 | ADVM | Adverum Biotechnol ... | Whitcup Scott M | Director | Option Exercise | A | 25.64 | 30,000 | 769,200 | 30,000 | |
| Jun 25 2020 | ADVM | Adverum Biotechnol ... | Lupher, Jr. Mark L. | Director | Option Exercise | A | 25.64 | 30,000 | 769,200 | 30,000 | |
| Jun 25 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | A | 25.64 | 30,000 | 769,200 | 30,000 | |
| Jun 25 2020 | ADVM | Adverum Biotechnol ... | Scopa James Paul | Director | Option Exercise | A | 25.64 | 30,000 | 769,200 | 30,000 | |
| Jun 25 2020 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Option Exercise | A | 25.64 | 30,000 | 769,200 | 30,000 | |
| Jun 25 2020 | ADVM | Adverum Biotechnol ... | Woiwode Thomas | Director | Option Exercise | A | 25.64 | 30,000 | 769,200 | 30,000 | |
| Jun 25 2020 | ADVM | Adverum Biotechnol ... | Hemrajani Rekha | Director | Option Exercise | A | 25.64 | 30,000 | 769,200 | 30,000 | |
| Jun 25 2020 | ADVM | Adverum Biotechnol ... | Carter Eric G | Director | Option Exercise | A | 25.64 | 30,000 | 769,200 | 30,000 | |
| Jun 23 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 23,605 | 113,304 | 83,000 | |
| Jun 23 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 25.06 | 23,605 | 591,617 | 274,442 | 298 K to 274.4 K (-7.92 %) |
| Jun 23 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 23,605 | 113,304 | 298,047 | 274.4 K to 298 K (+8.60 %) |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 11,127 | 53,410 | 106,605 | |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 11,127 | 53,410 | 106,605 | |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 268 | 1,286 | 117,732 | |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 268 | 1,286 | 117,732 | |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 25.01 | 11,127 | 278,329 | 274,442 | 285.6 K to 274.4 K (-3.90 %) |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 25.01 | 11,127 | 278,329 | 274,442 | 285.6 K to 274.4 K (-3.90 %) |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 11,127 | 53,410 | 285,569 | 274.4 K to 285.6 K (+4.05 %) |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 11,127 | 53,410 | 285,569 | 274.4 K to 285.6 K (+4.05 %) |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 25.01 | 268 | 6,703 | 274,442 | 274.7 K to 274.4 K (-0.10 %) |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 25.01 | 268 | 6,703 | 274,442 | 274.7 K to 274.4 K (-0.10 %) |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 268 | 1,286 | 274,710 | 274.4 K to 274.7 K (+0.10 %) |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 268 | 1,286 | 274,710 | 274.4 K to 274.7 K (+0.10 %) |
| Jun 17 2020 | ADVM | Adverum Biotechnol ... | PATTERSON LEONE D | President | Sell | S | 24.68 | 13,171 | 325,060 | 110,488 | 123.7 K to 110.5 K (-10.65 %) |
| Jun 17 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 10,000 | 48,000 | 118,000 | |
| Jun 17 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 23.59 | 159 | 3,751 | 274,442 | 274.6 K to 274.4 K (-0.06 %) |
| Jun 17 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 23.00 | 3,425 | 78,787 | 274,601 | 278 K to 274.6 K (-1.23 %) |
| Jun 17 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 21.93 | 1,416 | 31,047 | 278,026 | 279.4 K to 278 K (-0.51 %) |
| Jun 17 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 21.01 | 5,000 | 105,042 | 279,442 | 284.4 K to 279.4 K (-1.76 %) |
| Jun 17 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 10,000 | 48,000 | 284,442 | 274.4 K to 284.4 K (+3.64 %) |
| Jun 17 2020 | ADVM | Adverum Biotechnol ... | Fischer Laurent | CEO and Director | Option Exercise | A | 23.70 | 1,200,000 | 28,440,000 | 1,200,000 | |
| May 22 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 3,599 | 17,275 | 128,000 | |
| May 22 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 1,401 | 6,725 | 131,599 | |
| May 22 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | S | 20.02 | 3,599 | 72,048 | 274,442 | 270.8 K to 274.4 K (+1.33 %) |
| May 22 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 3,599 | 17,275 | 278,041 | 274.4 K to 278 K (+1.31 %) |
| May 22 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 20.01 | 1,401 | 28,030 | 274,442 | 275.8 K to 274.4 K (-0.51 %) |
| May 22 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 1,401 | 6,725 | 275,843 | 274.4 K to 275.8 K (+0.51 %) |
| May 20 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 5,000 | 24,000 | 133,000 | |
| May 20 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 25,000 | 120,000 | 138,000 | |
| May 20 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 10,000 | 48,000 | 163,000 | |
| May 20 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 19.03 | 300 | 5,709 | 274,442 | 274.7 K to 274.4 K (-0.11 %) |
| May 20 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 18.11 | 4,700 | 85,124 | 274,742 | 279.4 K to 274.7 K (-1.68 %) |
| May 20 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 5,000 | 24,000 | 279,442 | 274.4 K to 279.4 K (+1.82 %) |
| May 20 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 20.03 | 25,000 | 500,668 | 274,442 | 299.4 K to 274.4 K (-8.35 %) |
| May 20 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 25,000 | 120,000 | 299,442 | 274.4 K to 299.4 K (+9.11 %) |
| May 20 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 16.26 | 10,000 | 162,573 | 274,442 | 284.4 K to 274.4 K (-3.52 %) |
| May 20 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 10,000 | 48,000 | 284,442 | 274.4 K to 284.4 K (+3.64 %) |
| May 08 2020 | ADVM | Adverum Biotechnol ... | PATTERSON LEONE D | CEO, President and ... | Option Exercise | M | 3.44 | 20,000 | 68,800 | 155,576 | |
| May 08 2020 | ADVM | Adverum Biotechnol ... | PATTERSON LEONE D | CEO, President and ... | Sell | S | 20.02 | 20,000 | 400,400 | 123,659 | 143.7 K to 123.7 K (-13.92 %) |
| May 08 2020 | ADVM | Adverum Biotechnol ... | PATTERSON LEONE D | CEO, President and ... | Buy | M | 3.44 | 20,000 | 68,800 | 143,659 | 123.7 K to 143.7 K (+16.17 %) |
| May 05 2020 | ADVM | Adverum Biotechnol ... | Scopa James Paul | Director | Option Exercise | M | 6.48 | 23,334 | 151,204 | 46,666 | |
| May 05 2020 | ADVM | Adverum Biotechnol ... | Scopa James Paul | Director | Buy | M | 6.48 | 23,334 | 151,204 | 53,334 | 30 K to 53.3 K (+77.78 %) |
| Apr 20 2020 | ADVM | Adverum Biotechnol ... | Whitcup Scott M | Director | Option Exercise | A | 11.62 | 60,000 | 697,200 | 60,000 | |
| Mar 25 2020 | ADVM | Adverum Biotechnol ... | PATTERSON LEONE D | CEO, President and ... | Option Exercise | M | 3.44 | 24,424 | 84,019 | 175,576 | |
| Mar 25 2020 | ADVM | Adverum Biotechnol ... | PATTERSON LEONE D | CEO, President and ... | Sell | S | 10.17 | 39,526 | 401,908 | 123,429 | 163 K to 123.4 K (-24.26 %) |
| Mar 25 2020 | ADVM | Adverum Biotechnol ... | PATTERSON LEONE D | CEO, President and ... | Buy | M | 3.44 | 24,424 | 84,019 | 162,955 | 138.5 K to 163 K (+17.63 %) |
| Mar 18 2020 | ADVM | Adverum Biotechnol ... | PATTERSON LEONE D | CEO, President and ... | Sell | S | 10.02 | 474 | 4,749 | 138,531 | 139 K to 138.5 K (-0.34 %) |
| Feb 25 2020 | ADVM | Adverum Biotechnol ... | Thedinga Angela | Chief Technology Of ... | Option Exercise | A | 14.85 | 150,000 | 2,226,750 | 150,000 | |
| Feb 21 2020 | ADVM | Adverum Biotechnol ... | Soparkar Peter | Chief Legal Officer | Option Exercise | A | 15.75 | 40,750 | 641,813 | 40,750 | |
| Feb 21 2020 | ADVM | Adverum Biotechnol ... | Leung Thomas | Chief Financial Off ... | Option Exercise | A | 15.75 | 120,000 | 1,890,000 | 120,000 | |
| Feb 21 2020 | ADVM | Adverum Biotechnol ... | Osborne Aaron | Chief Medical Offic ... | Option Exercise | A | 15.75 | 150,000 | 2,362,500 | 150,000 | |
| Feb 21 2020 | ADVM | Adverum Biotechnol ... | PATTERSON LEONE D | CEO, President and ... | Option Exercise | A | 15.75 | 300,000 | 4,725,000 | 300,000 | |
| Feb 20 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 5,000 | 24,000 | 173,000 | |
| Feb 20 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 16.23 | 5,000 | 81,156 | 258,979 | 264 K to 259 K (-1.89 %) |
| Feb 20 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 5,000 | 24,000 | 263,979 | 259 K to 264 K (+1.93 %) |
| Feb 14 2020 | ADVM | Adverum Biotechnol ... | Scopa James Paul | Director | Buy | P | 13.75 | 10,000 | 137,500 | 30,000 | 20 K to 30 K (+50.00 %) |
| Feb 14 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 10,000 | 48,000 | 178,000 | |
| Feb 14 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 15.07 | 10,000 | 150,690 | 258,979 | 269 K to 259 K (-3.72 %) |
| Feb 14 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 10,000 | 48,000 | 268,979 | 259 K to 269 K (+3.86 %) |
| Feb 14 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 15.05 | 15,494 | 233,185 | 258,979 | 274.5 K to 259 K (-5.64 %) |
| Feb 14 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 11.33 | 31,451 | 356,340 | 289,967 | 321.4 K to 290 K (-9.79 %) |
| Feb 14 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Grant | A | 0.00 | 88,496 | 0 | 321,418 | 232.9 K to 321.4 K (+37.99 %) |
| Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 10.24 | 11,551 | 118,282 | 309,867 | 321.4 K to 309.9 K (-3.59 %) |
| Feb 10 2020 | ADVM | Adverum Biotechnol ... | PATTERSON LEONE D | CEO, President and ... | Payment of Exercise | F | 10.24 | 11,215 | 114,842 | 139,005 | 150.2 K to 139 K (-7.47 %) |
| Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 5.98 | 589 | 3,522 | 321,418 | 322 K to 321.4 K (-0.18 %) |
| Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 3.55 | 10,652 | 37,815 | 322,007 | 332.7 K to 322 K (-3.20 %) |
| Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 3.33 | 12,599 | 41,955 | 332,659 | 345.3 K to 332.7 K (-3.65 %) |
| Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 6.30 | 605 | 3,812 | 247,762 | 248.4 K to 247.8 K (-0.24 %) |
| Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 6.85 | 10,806 | 74,021 | 248,367 | 259.2 K to 248.4 K (-4.17 %) |
| Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 7.05 | 11,433 | 80,603 | 259,173 | 270.6 K to 259.2 K (-4.22 %) |
| Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 2.50 | 5,479 | 13,698 | 270,606 | 276.1 K to 270.6 K (-1.98 %) |
| Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 2.70 | 657 | 1,774 | 276,085 | 276.7 K to 276.1 K (-0.24 %) |
| Feb 10 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Payment of Exercise | F | 3.00 | 12,793 | 38,379 | 276,742 | 289.5 K to 276.7 K (-4.42 %) |
| Feb 10 2020 | ADVM | Adverum Biotechnol ... | PATTERSON LEONE D | CEO, President and ... | Payment of Exercise | F | 10.82 | 35,282 | 381,751 | 190,220 | 225.5 K to 190.2 K (-15.65 %) |
| Feb 10 2020 | ADVM | Adverum Biotechnol ... | PATTERSON LEONE D | CEO, President and ... | Payment of Exercise | F | 10.82 | 8,570 | 92,727 | 225,502 | 234.1 K to 225.5 K (-3.66 %) |
| Feb 10 2020 | ADVM | Adverum Biotechnol ... | PATTERSON LEONE D | CEO, President and ... | Payment of Exercise | F | 3.33 | 8,176 | 27,226 | 234,072 | 242.2 K to 234.1 K (-3.38 %) |
| Feb 10 2020 | ADVM | Adverum Biotechnol ... | PATTERSON LEONE D | CEO, President and ... | Payment of Exercise | F | 5.55 | 8,645 | 47,980 | 242,248 | 250.9 K to 242.2 K (-3.45 %) |
| Feb 10 2020 | ADVM | Adverum Biotechnol ... | PATTERSON LEONE D | CEO, President and ... | Payment of Exercise | F | 7.05 | 8,208 | 57,866 | 162,397 | 170.6 K to 162.4 K (-4.81 %) |
| Feb 10 2020 | ADVM | Adverum Biotechnol ... | PATTERSON LEONE D | CEO, President and ... | Payment of Exercise | F | 2.70 | 9,395 | 25,367 | 170,605 | 180 K to 170.6 K (-5.22 %) |
| Jan 03 2020 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Option Exercise | A | 11.52 | 15,000 | 172,800 | 15,000 | |
| Jan 03 2020 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Option Exercise | A | 11.52 | 15,000 | 172,800 | 15,000 | |
| Dec 26 2019 | ADVM | Adverum Biotechnol ... | PATTERSON LEONE D | CEO, President and ... | Sell | S | 10.72 | 40,000 | 428,800 | 228,496 | 268.5 K to 228.5 K (-14.90 %) |
| Nov 01 2019 | ADVM | Adverum Biotechnol ... | Soparkar Peter | Chief Legal Officer | Option Exercise | A | 6.88 | 400,000 | 2,752,000 | 400,000 | |
| Aug 16 2019 | ADVM | Adverum Biotechnol ... | Lupher, Jr. Mark L. | Director | Option Exercise | A | 13.41 | 33,750 | 452,588 | 45,000 | |
| Aug 16 2019 | ADVM | Adverum Biotechnol ... | Hemrajani Rekha | Director | Option Exercise | A | 13.41 | 33,750 | 452,588 | 45,000 | |
| Aug 16 2019 | ADVM | Adverum Biotechnol ... | Scopa James Paul | Director | Option Exercise | A | 13.41 | 33,750 | 452,588 | 45,000 | |
| Aug 16 2019 | ADVM | Adverum Biotechnol ... | Lupher, Jr. Mark L. | Director | Option Exercise | A | 13.41 | 33,750 | 452,588 | 45,000 | |
| Aug 16 2019 | ADVM | Adverum Biotechnol ... | Hemrajani Rekha | Director | Option Exercise | A | 13.41 | 33,750 | 452,588 | 45,000 | |
| Aug 16 2019 | ADVM | Adverum Biotechnol ... | Scopa James Paul | Director | Option Exercise | A | 13.41 | 33,750 | 452,588 | 45,000 | |
| Aug 02 2019 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Option Exercise | A | 13.41 | 45,000 | 603,450 | 45,000 | |
| Aug 02 2019 | ADVM | Adverum Biotechnol ... | Spivey Richard N. | Director | Option Exercise | A | 13.41 | 45,000 | 603,450 | 45,000 | |
| Aug 02 2019 | ADVM | Adverum Biotechnol ... | Carter Eric G | Director | Option Exercise | A | 13.41 | 45,000 | 603,450 | 45,000 | |
| Aug 02 2019 | ADVM | Adverum Biotechnol ... | Woiwode Thomas | Director | Option Exercise | A | 13.41 | 45,000 | 603,450 | 45,000 | |
| Aug 02 2019 | ADVM | Adverum Biotechnol ... | Finer Mitchell H. | Director | Option Exercise | A | 13.41 | 45,000 | 603,450 | 45,000 | |
| Aug 02 2019 | ADVM | Adverum Biotechnol ... | Scopa James Paul | Director | Option Exercise | A | 13.41 | 11,250 | 150,863 | 11,250 | |
| Aug 02 2019 | ADVM | Adverum Biotechnol ... | Lupher, Jr. Mark L. | Director | Option Exercise | A | 13.41 | 11,250 | 150,863 | 11,250 | |
| Aug 02 2019 | ADVM | Adverum Biotechnol ... | Hemrajani Rekha | Director | Option Exercise | A | 13.41 | 11,250 | 150,863 | 11,250 | |
| May 06 2019 | ADVM | Adverum Biotechnol ... | Scopa James Paul | Director | Buy | P | 6.71 | 20,000 | 134,200 | 20,000 | 0 to 20 K |
| May 03 2019 | ADVM | Adverum Biotechnol ... | Scopa James Paul | Director | Option Exercise | A | 6.48 | 70,000 | 453,600 | 70,000 | |
| May 03 2019 | ADVM | Adverum Biotechnol ... | Lupher, Jr. Mark L. | Director | Option Exercise | A | 6.48 | 70,000 | 453,600 | 70,000 | |
| May 03 2019 | ADVM | Adverum Biotechnol ... | Hemrajani Rekha | Director | Option Exercise | A | 6.48 | 70,000 | 453,600 | 70,000 | |
| Apr 25 2019 | ADVM | Adverum Biotechnol ... | Leung Thomas | Chief Financial Off ... | Option Exercise | A | 6.62 | 450,000 | 2,979,000 | 450,000 | |
| Apr 02 2019 | ADVM | Adverum Biotechnol ... | Osborne Aaron | Chief Medical Offic ... | Option Exercise | A | 5.41 | 450,000 | 2,434,500 | 450,000 | |
| Feb 19 2019 | ADVM | Adverum Biotechnol ... | Cheng Jennifer C. | General Counsel | Option Exercise | A | 3.50 | 80,000 | 280,000 | 80,000 | |
| Feb 19 2019 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | President and CSO | Option Exercise | A | 3.50 | 225,000 | 787,500 | 225,000 | |
| Feb 19 2019 | ADVM | Adverum Biotechnol ... | PATTERSON LEONE D | CEO, CFO and Direct ... | Option Exercise | A | 3.50 | 800,000 | 2,800,000 | 800,000 | |
| Oct 22 2018 | ADVM | Adverum Biotechnol ... | PATTERSON LEONE D | President, CEO and ... | Option Exercise | A | 4.70 | 150,000 | 705,000 | 150,000 | |
| Jun 18 2018 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Chief Science & Tec ... | Grant | A | 0.00 | 88,496 | 0 | 387,031 | 298.5 K to 387 K (+29.64 %) |
| Jun 18 2018 | ADVM | Adverum Biotechnol ... | Cheng Jennifer C. | General Counsel | Grant | A | 0.00 | 11,150 | 0 | 118,863 | 107.7 K to 118.9 K (+10.35 %) |